Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DOES COVID-19 INFECTION AND/OR VACCINATION OF PREGNANT WOMEN AFFECT THE PANCREATIC BETA CELLS OF THE FETUS BECOMING A TRIGGER FOR FUTURE DEVELOPMENT OF CHILDHOOD TYPE 1 DIABETES

NCT04860908 is registered in ClinicalTrials.gov with Maaynei Hayesha Medical Center as lead sponsor.

NCT NCT04860908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04860908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DOES COVID-19 INFECTION AND/OR VACCINATION OF PREGNANT WOMEN AFFECT THE PANCREATIC BETA CELLS OF THE FETUS BECOMING A TRIGGER FOR FUTURE DEVELOPMENT OF CHILDHOOD TYPE 1 DIABETES
Lead sponsor
Maaynei Hayesha Medical Center
Phase
Observational
Overall status
Unknown status
Start date
April 26, 2021
Completion date
July 1, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

generation of anti covid-19 antibodies in a fetus, whose mother was exposed to covid or was vaccinated during pregnancy